Edition:
United Kingdom

Claris Lifesciences Ltd (CLAI.BO)

CLAI.BO on Bombay Stock Exchange

392.50INR
9:59am GMT
Change (% chg)

Rs2.55 (+0.65%)
Prev Close
Rs389.95
Open
Rs390.00
Day's High
Rs393.85
Day's Low
Rs387.00
Volume
134,554
Avg. Vol
158,834
52-wk High
Rs425.70
52-wk Low
Rs308.00

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Dec 20.66 7.852
Sep 43.10 3.578
Jun 31.32 -1.647
FY 2017 Mar '17 27.41 -1.189
Dec 45.47 -4.501
Sep 17.92 -1.271
Jun 13.55 -0.840
FY 2016 Mar '16 182.38 -1.659
Dec 256.68 -16.928
Sep 1,972.88 2.199
Jun 1,870.79 3.526
 
*Note: Units in Millions ofRupee
**Note: Units in Rupee

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 31.10 32.90
P/E High - Last 5 Yrs. -- 40.92 45.97
P/E Low - Last 5 Yrs. -- 23.79 24.37
Beta 0.82 0.90 0.89
Price to Sales (TTM) 102.07 3.98 5.77
Price to Book (MRQ) -- 4.84 5.41
Price to Tangible Book (MRQ) -- 5.66 6.98
Price to Cash Flow (TTM) -- 23.02 23.42
% Owned Institutions -- 1.25 2.22

Dividends

  Company industry sector
Dividend Yield 0.55 1.57 1.50
Dividend Yield - 5 Year Avg -- 1.58 1.52
Dividend 5 Year Growth Rate -- 4.33 5.21
Payout Ratio(TTM) -- 45.86 43.72

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago 131.11 3.67 9.24
Sales (TTM) vs TTM 1 Yr. Ago 137.06 4.72 5.59
Sales - 5 Yr. Growth Rate -- 10.02 10.27
EPS (MRQ) vs Qtr. 1 Yr. Ago -95.99 16.64 19.65
EPS (TTM) vs TTM 1 Yr. Ago 68.15 -- --
EPS - 5 Yr. Growth Rate -- 9.82 10.73
Capital Spending - 5 Yr. Growth Rate -- 15.22 15.19

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.11 2.18
Current Ratio (MRQ) -- 2.89 2.97
LT Debt to Equity (MRQ) -- 9.91 12.22
Total Debt to Equity (MRQ) -- 13.93 16.52
Interest Coverage (TTM) -1.48 36.27 33.13

Profitability Ratios

  Company industry sector
Gross Margin (TTM) 72.14 55.11 54.70
Gross Margin - 5 Yr. Avg. -- 52.40 52.42
EBITD Margin (TTM) -358.32 -- --
EBITD - 5 Yr. Avg -- 18.51 10.86
Operating Margin (TTM) -375.91 14.36 4.64
Operating Margin - 5 Yr. Avg. -- 14.42 6.26
Pre-Tax Margin (TTM) -336.83 14.77 5.44
Pre-Tax Margin - 5 Yr. Avg. -- 14.73 6.60
Net Profit Margin (TTM) -219.89 11.05 1.76
Net Profit Margin - 5 Yr. Avg. -- 11.07 2.91
Effective Tax Rate (TTM) -- 23.16 23.04
Effective Tax Rate - 5 Yr. Avg. -- 23.41 23.96

Efficiency

  Company industry sector
Revenue/Employee (TTM) 118,782 948,737,542 855,667,832
Net Income/Employee (TTM) -261,187 111,622,076 100,655,557
Receivable Turnover (TTM) -- 5.62 5.78
Inventory Turnover (TTM) -- 2.58 3.35
Asset Turnover (TTM) -- 0.95 0.93

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -- 11.45 10.98
Return on Assets - 5 Yr. Avg. -- 12.98 12.37
Return on Investment (TTM) -- 14.90 14.43
Return on Investment - 5 Yr. Avg. -- 16.98 16.18
Return on Equity (TTM) -- 16.41 16.13
Return on Equity - 5 Yr. Avg. -- 18.08 17.47
  1 Year 3 Year 5 Year
Sales % -80.83 -- --
EPS (TTM) % 63.72 -- --
Dividend % 0.00 -- --
Note: Units in Millions of US Dollars

Performance for Claris Lifesciences Ltd

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week -2.19 -2.58 99 25
13 Week 0.70 -0.73 99 35
26 Week 10.79 3.45 99 30
52 Week 30.38 15.18 99 12
YTD 13.86 -4.71 99 25
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 14.87%
# of Holders: 10
Total Shares Held: 8,113,859
3 Mo. Net Change: -1,495,026
# New Positions: 0
# Closed Positions: 0
# Increased Positions: 0
# Reduced Positions: 1
# Net Buyers: -1
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.